Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Nov 21;98(3):517-27.
doi: 10.1016/0006-8993(75)90370-4.

Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats

G R Breese, B R Cooper

Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats

G R Breese et al. Brain Res. .

Abstract

Intracisternal administration of 200 mug of 5,7-dihydroxytryptamine (5,7-DHT) caused a prolonged reduction of brain serotonin which was accompanied by a depletion of brain norepinephrine. The depletion of norepinephrine was found to be antagonized by agents that inhibit uptake of norepinephrine as well as by several monoamine oxidase inhibitors. Intracisternal injections of 5,7-DHT (75 or 100 mug) to 7-day-old neonatal rats reduced brain serotonin and norepinephrine and produced a significant reduction of adult body weight. As in adults, pretreatment of neonatal rats with pargyline or desipramine prevented 5,7-DHT induced depletion of norepinephrine without affecting depletion of serotonin. Behaviorally, treatment of adult rats with 5,7-DHT facilitated acquisition of an active avoidance task and enhanced muricidal behavior. 5,7-DHT treatment was also found to enhance the depressant effects of 5-hydroxytryptophan on a fixed-ratio barpress response, suggesting that 5,7-DHT treated rats are supersensitive to serotonin in the central nervous system.

PubMed Disclaimer

References

    1. Aprison MH, Ferster CB. Neurochemical correlates of behavior: correlation of brain monoamine oxidase activity with behavioral changes after iproniazid and 5-hydroxytryptophan. J. Neurochem. 1961;6:350–357. - PubMed
    1. Baumgarten HG, Björklund A, Holstein AF, Nobin A. Chemical degeneration of inolamine axons in rat brain by 5,6-dihydroxytryptamine; an ultrastructural study. Z. Zellforsch. 1972;129:256–271. - PubMed
    1. Baumgarten HG, Björklund A, Lachenmayer L, Nobin A, Stenevi U. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine. Acta physiol, scand. 1971 Suppl. 373:1–15. - PubMed
    1. Baumgarten HG, Björklund A, Lachenmayer L, Nobin A. Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. Acta physiol. scand. 1973 Suppl. 391:1–19. - PubMed
    1. Baumgarten HG, Björklund A, Lachenmayer L, Rensch A, Rosengren E. De- and regeneration of the bulbospinal serotonin neurons in the rat following 5,6-dihydroxytryptamine treatment. Cell Tissue Res. 1974;152:271–281. - PubMed

Publication types

MeSH terms